Phosphorus acid functionalized coating composition
US-2016369359-A1 · Dec 22, 2016 · US
US2020385506A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020385506-A1 |
| Application number | US-202016892980-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 4, 2020 |
| Priority date | Jun 5, 2019 |
| Publication date | Dec 10, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are compositions to use in biofouling-resistant coatings, biofouling-resistant coatings, methods of making biofouling-resistant coatings, biofouling-resistant devices, and methods of making biofouling-resistant devices.
Opening claim text (preview).
1 . A copolymer comprising: a) a repeating unit of Formula (VII): wherein each R 1a and R 1b is independently selected from hydrogen and halogen; each R 2a and R 2b is independently selected from halogen, —CN, and optionally substituted C 1 -C 6 fluoroalkyl; each A 1 and A 2 is independently selected from —C(═O)—, —S(═O)—, —S(═O) 2 —, and —S(═O)(═NR 3c )—; each B 1 and B 2 is independently selected from —O— and —NR 3c ; Z 1 is —(CR 6c R 6d ) s —; each R 4c , R 4d , R 5d , R 5e , R 6c , and R 6d is independently selected from hydrogen, halogen, —CN, —OR 9a , optionally substituted C 1 -C 4 alkyl, optionally substituted C 1 -C 4 fluoroalkyl, optionally substituted C 2 -C 6 alkenyl, —NR 3c R 3d , —S(═O) 2 O − , —S(═O) 2 OR 9a , —C(═O)O − , and —C(═O)OR 9a ; each R 3c and R 3d is independently selected from hydrogen, optionally substituted C 1 -C 4 alkyl, —X-optionally substituted C 1 -C 4 alkyl, optionally substituted C 2 -C 6 alkenyl, and optionally substituted aryl; X is —C(═O)—, —S(═O)—, or —S(═O) 2 —; each R 9a , R 11a , R 11b and R 11c is independently selected from hydrogen, optionally substituted C 1 -C 4 alkyl, and optionally substituted aryl; n is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, and 8; and s is an integer selected from 1, 2, 3, 4, and 5; b) a repeating unit of Formula (VIII): wherein, A 3 is —C(═O)—, —S(═O)—, —S(═O) 2 —, or —S(═O)(═NR 3c )—; B 3 is —O— or —NR 3c —; D is —S(═O) 2 O − , —S(═O) 2 OR 9a , —C(═O)O − , or —C(═O)OR 9a ; Z 2 is —(CR 6c R 6d ) t —; Z 3 is —(CR 6c R 6d ) p —; each R 3a and R 3b is independently selected from hydrogen, optionally substituted C 1 -C 4 alkyl, and optionally substituted benzyl; each R 6C and R 6d is independently selected from hydrogen, halogen, —CN, —OR 9a , optionally substituted C 1 -C 4 alkyl, optionally substituted C 1 -C 4 fluoroalkyl, optionally substituted C 2 -C 6 alkenyl, —NR 3c R 3d , —S(═O) 2 O − , —S(═O) 2 OR 9a , —C(═O)O − , and —C(═O)OR 9a ; each R 3c and R 3d is independently selected from hydrogen, optionally substituted C 1 -C 4 alkyl, —X-optionally substituted C 1 -C 4 alkyl, optionally substituted C 2 -C 6 alkenyl, and optionally substituted aryl; X is —C(═O)—, —S(═O)—, or —S(═O) 2 —; each R 9a , R 12a , R 12b and R 12c is independently selected from hydrogen, optionally substituted C 1 -C 4 alkyl, and optionally substituted aryl; t is an integer selected from 1, 2, 3, 4, or 5; p is an integer selected from 1, 2, 3, 4, or 5; and wherein the repeating unit of Formula (VIII) is charged or zwitterionic; and c) a repeating unit of Formula (IX): A 4 is —C(═O)—, —S(═O)—, —S(═O) 2 —, or —S(═O)(═NR 3c )—; B 4 is —O— or —NR 3c —; Z 4 is —(CR 6c R 6d ) k —; E is —CN, —OR 9a , —NR 9a R 9b , —NR 9a R 9b R 9c+ optionally substituted C 1 -C 4 alkyl, optionally substituted C 1 -C 6 fluoroalkyl, —S(═O) 2 O − , —S(═O) 2 OR 9a , —C(═O)O − , or —C(═O)OR 9a ; each R 6c , and R 6d is independently selected from hydrogen, halogen, —CN, —OR 9a , optionally substituted C 1 -C 4 alkyl, optionally substituted C 1 -C 4 fluoroalkyl, optionally substituted C 2 -C 6 alkenyl, —NR 3c R 3d , —S(═O) 2 O − , —S(═O) 2 OR 9a , —C(═O)O − , and —C(═O)OR 9a ; each R 3c and R 3d is independently selected from hydrogen, optionally substituted C 1 -C 4 alkyl, —X-optionally substituted C 1 -C 4 alkyl, optionally substituted C 2 -C 6 alkenyl, and optionally substituted aryl; X is —C(═O)—, —S(═O)—, or —S(═O) 2 —; each R 9a , R 9b , R 9c , R 13a , R 13b , and R 13c is independently selected from hydrogen, optionally substituted C 1 -C 4 alkyl, and optionally substituted aryl; and k is an integer selected from 1, 2, 3, 4, or 5. 2 . The copolymer of claim 1 , wherein each R 1a , R 1b , R 2a , and R 2b is F. 3 . The copolymer of claim 1 , wherein A is —S(═O) 2 — and each A 2 , A 3 , and A 4 is —C(═O)—. 4 . The copolymer of claim 1 , wherein each B 1 , B 2 , and B 3 is independently —O— or —NR 3c —. 5 . The copolymer of claim 4 , wherein each R 3c is hydrogen or —CH 3 . 6 . The copolymer of claim 1 , wherein D is —S(═O) 2 O − or —C(═O)O − . 7 . The copolymer of claim 1 , wherein E is —NR 9a R 9b R 9c+ or —S(═O) 2 OR 9a . 8 . The copolymer of claim 7 , wherein each R 9a , R 9b , and R 9c is independently hydrogen or C 1 -C 4 alkyl. 9 . The copolymer of claim 1 , wherein each R 3a and R 3b is —CH 3 . 10 . The copolymer of claim 1 , wherein each R 3c , R 3d , R 4c , R 4d , R 5d , R 5e , R 6c , and R 6d is hydrogen. 11 . The copolymer of claim 1 , wherein each R 11a , R 12a , and R 13a is hydrogen or —CH 3 . 12 . The copolymer of claim 1 , wherein each R 11b , R 11c , R 12b , R 12c , R 13b , and R 13c is hydrogen. 13 . The copolymer of claim 1 , wherein n is 0, 1, or 2. 14 . The copolymer of claim 1 , wherein each s, t, p, and k is independently 1, 2 or 3. 15 . A medical device coated with a compound of claim 1 . 16 . A biofouling-resistant medical device, wherein a surface of the medical device is coated with a compound of claim 1 . 17 . The biofouling-resistant medical device of claim 16 , wherein the medical device comprises an implant, an IV, a prosthesis, suturing material, valve, stent, catheter, rod, shunt, scope, a contact lens, tubing, wiring, electrode, clip, fastener, syringe, container, or a combination thereof. 18 . The biofouling-resistant medical device of claim 17 , wherein the medical device is a catheter. 19 . The biofouling-resistant medical device of claim 16 , wherein the biofouling is produced by a bacterium, a virus, and/or a fungus. 20 . A method of making a biofouling-resistant medical device, comprising: a) contacting a surface of a device with a mixture comprising a charged or zwitterion copolymer; and b) treating the surface of the device of step a) with a heat source for a time sufficient to undergo thermografting of the copolymer onto the surface of the device, thereby making the biofouling-resistant device; wherein the charged or zwitterion copolymer comprises a phenyl azide-based copolymer; and wherein the charged or zwitterion copolymer having a number-average molecular weight of between about 10,000 and about 250,000. 21 .- 30 . (canceled)
of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen · CPC title
Vinyl-type polymers · CPC title
and containing other heteroatoms, e.g. 2-acrylamido-2-methylpropane sulfonic acid [AMPS] · CPC title
and containing nitrogen · CPC title
and containing a polyether chain in the alcohol moiety · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.